SEC Form 4 · accession 0001209191-18-045892
ANAPTYSBIO, INC · ANAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric J Loumeau
Officer — General Counsel
Period of report
Aug 6, 2018
Accepted (ET)
Aug 8, 2018 · 5:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001370053
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $78.18 | Aug 6, 2018 | A | 40,000 | A | — | Aug 5, 2028 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The option vests over a 4 year period: 25% vest and become exercisable on August 6, 2019, after which 1/48th of the total shares vest and become exercisable monthly thereafter, subject to reporting person's continuous service through each vesting date.